Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users

Peter A. Selwyn, Ellie Schoenbaum, K. Davenny, V. J. Robertson, A. R. Feingold, J. F. Shulman, Marguerite M. Mayers, R. S. Klein, G. H. Friedland, M. F. Rogers

Research output: Contribution to journalArticle

161 Citations (Scopus)

Abstract

To determine the effects of human immunodeficiency virus (HIV) infection on pregnancy outcomes, we prospectively studied female intravenous drug users in a methadone program in New York City. Of 191 women with HIV status known prior to pregnancy, 17 (24%) of 70 seropositives and 26 (22%) of 21 seronegatives became pregnant during 28 months of follow-up. Including 54 additional women first tested for HIV antibody after becoming pregnant, 125 pregnancies were studied in 97 women (39 seropositive, 58 seronegative). None of the seropositive pregnant women had advanced HIV-related disease at entry, and only one developed symptomatic disease (oral candidiasis) during pregnancy. No differences were observed between groups in the frequency of spontaneous or elective abortion, ectopic pregnancy, preterm delivery, stillbirth, or low-birthweight births. Among women giving birth to live infants, seropositives were more likely than seronegatives to be hospitalized for bacterial pneumonia during pregnancy and had an increased tendency for breech presentation, although these events were infrequent. There were otherwise no differences between groups in the occurrence of antenatal, intrapartum, or neonatal complications. Results suggest that asymptomatic HIV infection is not associated with a decreased pregnancy rate or an increased risk of adverse pregnancy outcomes in intravenous drug users, and that an acceleration in HIV-disease status during pregnancy is uncommon.

Original languageEnglish (US)
Pages (from-to)1289-1294
Number of pages6
JournalJournal of the American Medical Association
Volume261
Issue number9
StatePublished - 1989

Fingerprint

Virus Diseases
Pregnancy Outcome
Drug Users
HIV
Prospective Studies
Pregnancy
Breech Presentation
Oral Candidiasis
Bacterial Pneumonia
Stillbirth
Ectopic Pregnancy
Methadone
Live Birth
Pregnancy Rate
Pregnant Women
Parturition
Antibodies

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users. / Selwyn, Peter A.; Schoenbaum, Ellie; Davenny, K.; Robertson, V. J.; Feingold, A. R.; Shulman, J. F.; Mayers, Marguerite M.; Klein, R. S.; Friedland, G. H.; Rogers, M. F.

In: Journal of the American Medical Association, Vol. 261, No. 9, 1989, p. 1289-1294.

Research output: Contribution to journalArticle

Selwyn, PA, Schoenbaum, E, Davenny, K, Robertson, VJ, Feingold, AR, Shulman, JF, Mayers, MM, Klein, RS, Friedland, GH & Rogers, MF 1989, 'Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users', Journal of the American Medical Association, vol. 261, no. 9, pp. 1289-1294.
Selwyn, Peter A. ; Schoenbaum, Ellie ; Davenny, K. ; Robertson, V. J. ; Feingold, A. R. ; Shulman, J. F. ; Mayers, Marguerite M. ; Klein, R. S. ; Friedland, G. H. ; Rogers, M. F. / Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users. In: Journal of the American Medical Association. 1989 ; Vol. 261, No. 9. pp. 1289-1294.
@article{fa55a6bd5c634d11b36232409244d9a8,
title = "Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users",
abstract = "To determine the effects of human immunodeficiency virus (HIV) infection on pregnancy outcomes, we prospectively studied female intravenous drug users in a methadone program in New York City. Of 191 women with HIV status known prior to pregnancy, 17 (24{\%}) of 70 seropositives and 26 (22{\%}) of 21 seronegatives became pregnant during 28 months of follow-up. Including 54 additional women first tested for HIV antibody after becoming pregnant, 125 pregnancies were studied in 97 women (39 seropositive, 58 seronegative). None of the seropositive pregnant women had advanced HIV-related disease at entry, and only one developed symptomatic disease (oral candidiasis) during pregnancy. No differences were observed between groups in the frequency of spontaneous or elective abortion, ectopic pregnancy, preterm delivery, stillbirth, or low-birthweight births. Among women giving birth to live infants, seropositives were more likely than seronegatives to be hospitalized for bacterial pneumonia during pregnancy and had an increased tendency for breech presentation, although these events were infrequent. There were otherwise no differences between groups in the occurrence of antenatal, intrapartum, or neonatal complications. Results suggest that asymptomatic HIV infection is not associated with a decreased pregnancy rate or an increased risk of adverse pregnancy outcomes in intravenous drug users, and that an acceleration in HIV-disease status during pregnancy is uncommon.",
author = "Selwyn, {Peter A.} and Ellie Schoenbaum and K. Davenny and Robertson, {V. J.} and Feingold, {A. R.} and Shulman, {J. F.} and Mayers, {Marguerite M.} and Klein, {R. S.} and Friedland, {G. H.} and Rogers, {M. F.}",
year = "1989",
language = "English (US)",
volume = "261",
pages = "1289--1294",
journal = "JAMA - Journal of the American Medical Association",
issn = "0002-9955",
publisher = "American Medical Association",
number = "9",

}

TY - JOUR

T1 - Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users

AU - Selwyn, Peter A.

AU - Schoenbaum, Ellie

AU - Davenny, K.

AU - Robertson, V. J.

AU - Feingold, A. R.

AU - Shulman, J. F.

AU - Mayers, Marguerite M.

AU - Klein, R. S.

AU - Friedland, G. H.

AU - Rogers, M. F.

PY - 1989

Y1 - 1989

N2 - To determine the effects of human immunodeficiency virus (HIV) infection on pregnancy outcomes, we prospectively studied female intravenous drug users in a methadone program in New York City. Of 191 women with HIV status known prior to pregnancy, 17 (24%) of 70 seropositives and 26 (22%) of 21 seronegatives became pregnant during 28 months of follow-up. Including 54 additional women first tested for HIV antibody after becoming pregnant, 125 pregnancies were studied in 97 women (39 seropositive, 58 seronegative). None of the seropositive pregnant women had advanced HIV-related disease at entry, and only one developed symptomatic disease (oral candidiasis) during pregnancy. No differences were observed between groups in the frequency of spontaneous or elective abortion, ectopic pregnancy, preterm delivery, stillbirth, or low-birthweight births. Among women giving birth to live infants, seropositives were more likely than seronegatives to be hospitalized for bacterial pneumonia during pregnancy and had an increased tendency for breech presentation, although these events were infrequent. There were otherwise no differences between groups in the occurrence of antenatal, intrapartum, or neonatal complications. Results suggest that asymptomatic HIV infection is not associated with a decreased pregnancy rate or an increased risk of adverse pregnancy outcomes in intravenous drug users, and that an acceleration in HIV-disease status during pregnancy is uncommon.

AB - To determine the effects of human immunodeficiency virus (HIV) infection on pregnancy outcomes, we prospectively studied female intravenous drug users in a methadone program in New York City. Of 191 women with HIV status known prior to pregnancy, 17 (24%) of 70 seropositives and 26 (22%) of 21 seronegatives became pregnant during 28 months of follow-up. Including 54 additional women first tested for HIV antibody after becoming pregnant, 125 pregnancies were studied in 97 women (39 seropositive, 58 seronegative). None of the seropositive pregnant women had advanced HIV-related disease at entry, and only one developed symptomatic disease (oral candidiasis) during pregnancy. No differences were observed between groups in the frequency of spontaneous or elective abortion, ectopic pregnancy, preterm delivery, stillbirth, or low-birthweight births. Among women giving birth to live infants, seropositives were more likely than seronegatives to be hospitalized for bacterial pneumonia during pregnancy and had an increased tendency for breech presentation, although these events were infrequent. There were otherwise no differences between groups in the occurrence of antenatal, intrapartum, or neonatal complications. Results suggest that asymptomatic HIV infection is not associated with a decreased pregnancy rate or an increased risk of adverse pregnancy outcomes in intravenous drug users, and that an acceleration in HIV-disease status during pregnancy is uncommon.

UR - http://www.scopus.com/inward/record.url?scp=0024518119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024518119&partnerID=8YFLogxK

M3 - Article

C2 - 2915455

AN - SCOPUS:0024518119

VL - 261

SP - 1289

EP - 1294

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0002-9955

IS - 9

ER -